DexTech Medical ABXSAT:DEX +2.91%32 Market Cap is kr195.95 Mil as of Jun. 29, 2026. GuruFocus rates XSAT:DEX with a GF Score™ of 32/100. The stock has 3 warning signs investors should review. Among 1,428 Biotechnology companies, DexTech Medical AB ranks worse than 75.49% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). DexTech Medical AB's share price for the quarter that ended in Mar. 2026 was kr10.1. DexTech Medical AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 18.49 Mil. Therefore, DexTech Medical AB's market cap for the quarter that ended in Mar. 2026 was kr186.71 Mil.
DexTech Medical AB's quarterly market cap
increased
from Sep. 2025 (kr168.22 Mil) to Dec. 2025 (kr169.15 Mil) and
increased
from Dec. 2025 (kr169.15 Mil) to Mar. 2026 (kr186.71 Mil).
DexTech Medical AB's annual market cap
declined
from Jun. 2023 (kr83.19 Mil) to Jun. 2024 (kr78.38 Mil) but then
increased
from Jun. 2024 (kr78.38 Mil) to Jun. 2025 (kr138.65 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. DexTech Medical AB's Enterprise Value for Today is kr185.83 Mil.
DexTech Medical AB (XSAT:DEX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
DexTech Medical AB Market Cap Related Terms
DexTech Medical AB Market Cap Historical Data
* Premium members only.
The historical data trend for DexTech Medical AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSAT:DEX vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, DexTech Medical AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DexTech Medical AB Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, DexTech Medical AB's Market Cap distribution charts can be found below:
* The bar in red indicates where DexTech Medical AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
DexTech Medical AB's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DexTech Medical AB (XSAT:DEX) has a Market Cap of kr195.95 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on DexTech Medical AB and its competitors. According to the industry distribution chart, DexTech Medical AB ranks #1078 out of 1428 companies in the Biotechnology industry, placing it in the top 75.5%.
Is DexTech Medical AB's Market Cap too high?
DexTech Medical AB's current Market Cap is kr195.95 Mil. Based on the distribution chart, DexTech Medical AB ranks #1078 out of 1428 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, DexTech Medical AB has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does DexTech Medical AB's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, DexTech Medical AB ranks #1078 out of 1428 companies for Market Cap. This places DexTech Medical AB in the lower half of its industry. The industry median Market Cap is 114.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 114.03, based on 1,428 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on DexTech Medical AB and its competitors. For the Biotechnology industry, the median Market Cap is 114.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DexTech Medical AB's current Market Cap is kr195.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DexTech Medical AB stock overvalued right now?
DexTech Medical AB (XSAT:DEX) has a current Market Cap of kr195.95 Mil. The current Market Cap is kr195.95 Mil. DexTech Medical AB's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For DexTech Medical AB (XSAT:DEX), the current Market Cap is kr195.95 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
DexTech Medical AB is a Swedish research company specializing in drug development for urological oncology, with a prominent focus on prostate cancer. The company develops drug candidates using a proprietary carbohydrate platform, advancing treatments aimed at castration-resistant prostate cancer and related conditions. Its operations center on research, development, and licensing of these drug candidates. It has four drug candidates: OsteoDex, SomaDex, PSMA-binding conjugates, and GuaDex.
32GF Score
Get the complete analysis for XSAT:DEX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:DEX has been successfully added to your 
